Search

Your search keyword '"Keenan, Jennifer"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Keenan, Jennifer" Remove constraint Author: "Keenan, Jennifer"
36 results on '"Keenan, Jennifer"'

Search Results

3. Factors That Can Impact Delivery of Inclusive Practices: Perspectives of General Education Teachers

4. Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child.

6. The Nature of Friendship between Students with and without Severe Disabilities

7. Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

10. Abstract 6744: Cell-free DNA detection of alterations in the MAPK pathway in metastatic hormone receptor positive breast cancer: A multi-institutional analysis of incidence and clinical outcomes

11. The Influence of Nature on Well-Being During the COVID-19 Pandemic: Views From New England Island Residents.

12. Abstract P4-01-14: Changes in the Genomic Spectrum of Actionable Alterations in HER2 Negative Metastatic Breast Cancer in Serial Cell Free DNA (cfDNA) Analysis

13. Abstract P1-08-01: Virtual molecular and precision medicine (vMAP) clinic to improve access to clinical trials for patients with metastatic breast cancer: an academic-community collaboration

14. Abstract P5-02-07: Cell-free DNA detection of GATA3 mutations in metastatic hormone receptor positive breast cancer: a retrospective, observational multi-institutional analysis

15. Abstract P5-02-13: TRK inhibitor in a patient with metastatic triple negative breast cancer and NTRK fusions identified via cell-free DNA analysis

16. Abstract P1-13-07: Investigating NF1 Mutations in Circulating Tumor DNA of Patients with Hormone-receptor Positive (HR+) Breast Tumors Resistant to CDK4/6 Inhibition (CDK4/6i): A Retrospective Clinical Analysis

17. Abstract PD13-07: PD13-07 Combination therapy with the AKT inhibitor, ipatasertib, endocrine therapy, and a CDK4/6 inhibitor for hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC): results from the phase I TAKTIC trial

19. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis

20. Abstract P1-18-22: AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) and prior CDK4/6i exposure: A translational investigation

22. A Statewide Public and Professional Education Program on Fragile X Syndrome.

23. Management of Metastatic Triple-negative Breast Cancer: Focus on Targeted Therapies.

25. Epimerase-deficiency galactosemia is not a binary condition

28. The Evolution of Moore's Law Through Chipletized Architectures.

29. The Nature of Friendship Between Students With and Without Severe Disabilities.

30. Prognostic value of TP53 mutation status in metastatic triple-negative and hormone receptor-positive breast cancer using cell-free DNA genomic profiling.

31. ESR1 mutational landscape and impact of co-existing resistance variants on clinical outcomes in patients with metastatic breast cancer.

32. Factors that can impact delivery of inclusive practices: perspectives of general education teachers

33. 2016 ASAHP Annual Conference: Abstracts of the Presentations…Improving Clinical Education by Centralizing Operations in a College of Health and Rehabilitation Sciences.

34. Teacher perspectives on indicators of adolescent social and emotional problems.

35. UMPNC: building a team with a visionary plan.

36. Organizing a union just makes sense!

Catalog

Books, media, physical & digital resources